Compare GRND & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRND | PBH |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.0B |
| IPO Year | N/A | 2005 |
| Metric | GRND | PBH |
|---|---|---|
| Price | $13.67 | $62.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $22.75 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 1.5M | 441.7K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.04 |
| Revenue | $411,545,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $29.03 | N/A |
| Revenue Next Year | $21.87 | $2.50 |
| P/E Ratio | ★ N/A | $15.24 |
| Revenue Growth | ★ 28.97 | N/A |
| 52 Week Low | $11.73 | $57.25 |
| 52 Week High | $25.13 | $90.04 |
| Indicator | GRND | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 59.74 |
| Support Level | $12.86 | $60.50 |
| Resistance Level | $13.94 | $62.40 |
| Average True Range (ATR) | 0.42 | 1.45 |
| MACD | 0.05 | 0.34 |
| Stochastic Oscillator | 73.15 | 83.88 |
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.